Society of General Internal Medicine
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Coding for Musculoskeletal System and Connective Tissue Diseases
Chapter 11 Coding for Musculoskeletal System and Connective Tissue Diseases Chapter Outline Objectives Musculoskeletal Disorders . Describe the pathology of common Arthritic Disorders musculoskeletal and connective tissue diseases. Chronic Versus Traumatic Joint Derangements . Recognize the typical manifestations, Pathologic Versus Traumatic Bone Fractures complications, and treatments of common Osteomyelitis musculoskeletal and connective tissue diseases in Necrotizing Fasciitis terms of their implications for coding. Costochondritis . Correctly code common musculoskeletal and Back and Spine Disorders connective tissue diseases by using the ICD-9-CM Connective Tissue Diseases and medical reports. Systemic Lupus Erythematosus Systemic Sclerosis Testing Your Comprehension Coding Practice I: Chapter Review Exercises Coding Practice II: Medical Record Case Studies Musculoskeletal and connective tissue diseases are classified in code section 710 to 739 of chapter 13 of the Disease Tabular of the ICD-9-CM, which includes diseases of the bones, muscles, joints, soft tissues, ligaments, tendons, and cartilage. To assist in your understanding, Table 11.1 reviews word parts and meanings of medical terms related to common musculoskeletal and connective tissue diseases. 283 284 Part II: Coding for Specific Diseases and Disorders Table 11.1 Word Parts and Meanings of Musculoskeletal and Connective Tissue Terms Word Part Meaning Example Definition of Example arthr/o joint arthritis Inflammation of a joint oste/o bone osteoarthritis Inflammation of -
Congenital Chloride Diarrhea in a Bartter Syndrome Misdiagnosed
Case Report iMedPub Journals Journal of Rare Disorders: Diagnosis & Therapy 2019 www.imedpub.com ISSN 2380-7245 Vol.5 No.2:4 DOI: 10.36648/2380-7245.5.2.196 Congenital Chloride Diarrhea in a Bartter Maria Helena Vaisbich*, Juliana Caires de Oliveira Syndrome Misdiagnosed Brazilian Patient Achili Ferreira, Ana Carola Hebbia Lobo Messa and Abstract Fernando Kok The differential diagnosis in children with hypokalemic hypochloremic alkalosis Department of Pediatric Nephrology, include a group of an inherited tubulopathies, such as Bartter Syndrome (BS) Instituto da Criança, University of São Paulo, and Gitelman Syndrome (GS). However, some of the clinically diagnosed São Paulo, Brasil patients present no pathogenic mutation in BS/GS known genes. Therefore, one can conclude that a similar clinical picture may be caused by PseudoBartter Syndrome (PBS) conditions. PBS include acquired renal problems (ex.: use of diuretics) as well as genetic or acquired extrarenal problems such as cystic *Corresponding author: fibrosis or cyclic vomiting, respectively. The accurate diagnosis of BS/GS needs Maria Helena Vaisbich a rational investigation. First step is to rule out PBS and confirm the primary renal tubular defect. However, it is not easy in some situations. In this sense, Department of Pediatric Nephrology, we reported a patient that was referred to our service with the diagnosis Instituto da Criança, University of São Paulo, of BS, but presented no mutation in BS/GS known genes. The whole-exome São Paulo, Brasil. sequencing detected a SCL26A3 likely pathogenic mutation leading to the final diagnosis of Congenital Chloride Diarrhea (CCD). Reviewing the records, the [email protected] authors noticed that liquid stools were mistaken for urine. -
Management of Hemorrhoid Complications in Persian Medicine
http://www.cjmb.org Open Access Review Article Crescent Journal of Medical and Biological Sciences Vol. 7, No. 4, October 2020, 457–466 eISSN 2148-9696 Management of Hemorrhoid Complications in Persian Medicine Khadijeh Hatami1, Amir-Hooman Kazemi-Motlagh1, Hossein Ajdarkosh2, Arman Zargaran1, Mehrdad Karimi1, Ali-Asghar Haeri Mehrizi3, Hoorieh Mohammadi Kenari4 Abstract Objectives: Hemorrhoid disease has been a common medical problem since ancient times. About 5%-10% of patients do not respond to conservative treatment, and surgical procedures have a 20%-25% complication rate including pain, stenosis, infection, incontinence, and the like. Thus, most patients and physicians seek alternative and complementary medicines. Persian medicine (PM) is one of the oldest traditional medicines that present different treatment methods for managing hemorrhoid complications. Accordingly, the present study reviewed these methods and their applications. Methods: This historical review surveyed the principle of management and different medicinal and non-medicinal treatments for each complication of hemorrhoid based on the main textbooks of disease-treatment and famous pharmacopoeias of PM from 10th to 18th century AD. Recent findings about their pharmaceutical properties and mechanisms of action were searched in Google Scholar, Science Direct, and PubMed databases. Results: In PM, it is believed that hemorrhoid disease is because of melancholic or sanguineous distemperament. Cleansing the body and then strengthening the gastrointestinal and the liver for more effective treatment and prevention of relapse are the first therapeutic approaches in this regard. They use herbal and non-herbal medicines with anti-oxidant and anti-inflammatory, analgesic, and phlebotonic properties. In addition, different methods of bloodletting are used for body cleansing, reducing pain, and treating bleeding or thrombotic hemorrhoids. -
Pseudo-Bartter Syndrome As the Initial Presentation of Cystic Fibrosis in Infants: a Paediatrics Section Paediatrics Series of Three Cases and Review of Literature
DOI: 10.7860/JCDR/2018/36189.11965 Case Series Pseudo-bartter Syndrome as the Initial Presentation of Cystic Fibrosis in Infants: A Paediatrics Section Paediatrics Series of Three cases and Review of Literature PRAWIN KUMAR1, NEERAJ GUPTA2, DAISY KHERA3, KULDEEP SINGH4 ABSTRACT Cystic Fibrosis (CF) is predominantly a disease of Caucasians, but it is increasingly being recognised in India. The typical presentations of CF are recurrent pneumonia and malabsorption. Atypical presentations are also increasingly being reported from India due to the differences in genotype and environmental factors. Pseudo-Bartter syndrome (PBS) is one of these atypical presentations which can present at any time after the diagnosis of CF but its presentation as an initial manifestation is rare. We hereby report three infants who presented with dehydration without obvious external losses. The investigations revealed metabolic alkalosis with hypochloraemia. A stepwise approach towards metabolic alkalosis revealed possibility of cystic fibrosis which was confirmed by sweat chloride test. All infants completely recovered with initial fluid and electrolyte therapy, following which supportive therapy for CF was started and subsequently they were discharged from the hospital. Keywords: Hypochloraemia, Metabolic alkalosis, Pseudo-Bartter Syndrome CASE SERIES sweat chloride test was not available at our centre so they were sent In this case series, we have described three infants in the age group to paediatric pulmonology division, AIIMS, New Delhi where sweat of 5-10 months from western Rajasthan, India, who presented with chloride test was performed (pilocarpine iontophoresis method), features of dehydration, without any evidence of obvious external which turned out to be positive (sweat chloride >60 mEq/L) in all fluid loss. -
Overview of Stroke: Etiologies, Demographics, Syndromes, And
Overview of Stroke: Etiologies, Demographics, Syndromes, and Outcomes Alex Abou-Chebl, MD, FSVIN Medical Director, Stroke Baptist Health Louisville Disclosure Statement of Financial Interest Within the past 12 months, I or my spouse/partner have had a financial interest/arrangement or affiliation with the organization(s) listed below. Affiliation/Financial Relationship Company Consulting Fees/Honoraria The Medicines Co. Silk Road Medical Definitions Stroke - abrupt development of a focal neurological deficit due to a vascular cause associated with permanent neuronal injury Transient ischemic attack (TIA)- same clinical syndrome as a stroke but resolves completely < 24 hours i.e. without permanent brain injury (old definition) With modern imaging most events >several hours duration are associated with infarction. Epidemiology- USA ~795,000 new or recurrent stroke per year 610,000 first attacks 185,000 recurrent attacks 2001 to 2011 relative rate of stroke death fell 35.1% Actual number of stroke deaths declined 23.0% In 2011 stroke caused ~1 of every 20 deaths in USA On average,1 stroke every 40 seconds in USA 1 Stroke death every 4 minutes There are ~ 4.5-5 million Stroke survivors Stroke is the leading cause of adult disability in USA 15-30% of all stroke leads to permanent disability Mozaffarian D, et al. Heart Disease and Stroke Statistics- 2015 Update. Circulation 2015;131:e29-322. Prevalence of Stroke by Age and Sex (National Health and Nutrition Examination Survey: 2009–2012). Dariush Mozaffarian et al. Circulation. 2015;131:e29-e322 Copyright © American Heart Association, Inc. All rights reserved. Annual Age-adjusted Incidence of First-ever Stroke by Race. -
Recreational Noise-Induced Hearing Loss
Hearing loss due to recreational exposure to loud sounds A review World Health Organization Hearing loss due to recreational exposure to loud sounds A review World Health Organization Contributors: Etienne Krug, Maria Alarcos Cieza, Shelly Chadha, Laura Sminkey, Thais Morata, DeWet Swanepoel, Adrian Fuente, Warwick Williams, Joseph Cerquone, Ricardo Martinez, Gretchen Stevens, Margie Peden, Sowmya Rao, Paras Agarwal, Eighmey Zeeck, Anna Bladey, Malachi Arunda, Aileen Ncube. Graphics Credits: INIS Communications WHO Library Cataloguing-in-Publication Data Hearing loss due to recreational exposure to loud sounds: a review. 1.Hearing Loss, Noise-Induced. 2.Music. 3.Noise. 4.Recreation. 5.Noise. Transportation. 6.Adolescent. I.World Health Organization. ISBN 978 92 4 150851 3 (NLM classification: WV 270) © World Health Organization 2015 All rights reserved. Publications of the World Health Organization are available on the WHO website (http://www.who.int) or can be purchased from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel.: +41 22 791 3264; fax: +41 22 791 4857; e-mail: [email protected]). Requests for permission to reproduce or translate WHO publications – whether for sale or for non- commercial distribution – should be addressed to WHO Press through the WHO website (http://www.who.int/about/licensing/copyright_form/en/index.html). The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. -
Edema II, Clinical Significance
EDEMA II CLINICAL SIGNIFICANCE F. A. LeFEVRE, M.D., R. H. McDONALD, M.D., AND A. C. CORCORAN, M.D. It is the purpose of this paper to outline the clinical syndromes in which edema significantly appears, to discuss their differentiation, and to comment on the changes to which edema itself may give rise. The frequency with which edema occurs indicates the variety of its origins. Its physiologic bases have been reviewed in a former paper.1 Conditions in which edema commonly appears are summarized in Table 1. Although clinical edema usually involves more than one physiologic mechanism, it is not difficult to determine the predominant disturbance. Table 2 illustrates the physiologic mechanisms of clinical edema. Physiologically, edema is an excessive accumulation of interstitial fluid. Clinically, it may be latent or manifest, and, by its nature, localized or generalizing. These terms, with the exception of generalizing, have been defined, and may be accepted. By generalizing edema is meant a condi- tion in which edema is at first local in its appearance, but in which, as the process extends, edema will become general, causing anasarca. The degree of edema in any area is limited by tissue tension and the sites of its first appearance and later spread are partly determined by gravity. CARDIAC EDEMA Generalizing edema is an early manifestation of cardiac failure. It is usually considered to be evidence of inadequacy of the right ventricu- lar musculature (back pressure theory). Peripheral edema may be accompanied by pulmonary edema in cases where there is simultaneous left ventricular failure. Actually, the genesis of cardiac edema may depend more on sodium retention2,3'4 due to "forward cardiac failure" and renal constriction than on venous back pressure alone. -
Post Hemorrhoidectomy Pain Relief; Outcome of Local Anesthesia
PAIN RELIEF POST HEMORRHOIDECTOMY The Professional Medical Journal www.theprofesional.com ORIGINAL PROF-2998 DOI: 10.17957/TPMJ/15.2998 POST HEMORRHOIDECTOMY PAIN RELIEF; OUTCOME OF LOCAL ANESTHESIA Dr. Syed Muhammad Maroof Hashmi1, Dr. Shua Nasir2, Dr. Lal Shehbaz3, Dr. Muhammad Absar Anwar4, Ahmed Ali5 1. Senior Registrar Department of Neurosurgery ABSTRACT… Background: The aim of my study is to evaluate post-operative pain relief K.M.D.C and Abbasi Shaheed on patients who had hemorrhoidectomy. Materials and Methods: 300 patients who had Hospital Karachi. hemorrhoidectomy were divided equally in to three groups, according to anesthesia type, 2. MD Resident Department of Emergency group 1 (local anesthesia and sedation), while spinal anesthesia was group 2 and general Medicine Ziauddin University anesthesia was considered to be group 3. Pain relief, post-operative complications, hospital Hospital Karachi. staying time were measured and compared between the three groups. Period: Study was 3. MD Resident performed between Jan 2012 to Dec 2014. Results: The study showed that patients who had Department of Emergency Medicine Ziauddin University local anesthesia infiltration and sedation a significant decrease of post-operative total pain Hospital Karachi. scores at 6/12/18/24 hours of more than 50%,200/240/300/320 out of 1000 points in group II 4. House Officer as compared to 420/500/540/580,700/680/660/660 in 3rd groups respectively. The total post- DUHS and Civil Hospital, Karachi 5. Research Fellow BMU operative analgesia doses in the 3 groups were 120:140:180 respectively, total hospital staying time were 130:210:260 days, headache in the ratio of 0:8:1, urine retention in 0:6:1 patients, Correspondence Address: nausea and vomiting in 0:1:5 patients were reduced by 30 %,. -
Cerebritis: an Unusual Complication of Klebsiella Pneumoniae
Case Report Cerebritis: An unusual complication of Klebsiella pneumoniae Mainak Majumdar, David C. Simes1, Ramesh D. Prabha1 Cerebritis is part of a continuum of brain infection and is difficult to diagnose. Cerebritis caused by Klebsiella in immunocompetent adults without predisposing factors such as neurosurgery or penetrating brain injury has not been reported before. We report a case of Klebsiella cerebritis in an adult patient with a proven extracranial focus of infection. We suggest considering cerebritis as a differential diagnosis for altered level of consciousness in patients Abstract of severe sepsis, even if an extracranial source of infection is proven. Key words: Alcohol, cerebritis, Klebsiella DOI: 10.4103/0972-5229.53116 Introduction heavy smoking, heavy ethanol use, and two prior hospital admissions for pneumonia and exacerbation of Cerebritis without a history of penetrating head chronic obstructive airways disease. trauma or neurosurgery is a rarely suspected cause of coma. Bacteria gain entry to brain tissue and cause infection either by direct spread or through At presentation she was febrile, delirious, and hematogenous seeding.[1] In Gram-negative CNS tachypneic with low oxygen saturations, relative infections, a primary focus of infection may be found hypotension, and new onset atrial fibrillation with a rapid ventricular response. Her chest X-ray revealed dense right in neonates and in trauma and neurosurgical patients, upper and middle lobe consolidation. Initial treatment but in adults without antecedent surgery, there will consisted of oxygen therapy, intravenous fluid resuscitation, be no primary focus of infection detected in up to noninvasive ventilation, and antibiotics (ceftriaxone and 60% of cases.[2] Further, sedation in the intensive care azithromycin) for her community acquired pneumonia. -
Practice Description –Institutional Setting (Hsc) – Internal Medicine
NOTE: REMEMBER TO HIGHLIGHT CHANGES YOU MAKE TO THIS DOCUMENT IN BLUE SCHEDULE A PRACTICE DESCRIPTION –INSTITUTIONAL SETTING (HSC) – INTERNAL MEDICINE AREAS HIGHLIGHTED IN GREEN ARE FOR GUIDANCE IN COMPLETING THIS DOCUMENT. THESE AREAS WILL BE DELETED WHEN THE DOCUMENT IS IN ITS FINAL FORM. AMEND/MODIFY AREAS HIGHLIGHTED IN YELLOW AS APPROPRIATE – ENSURE ALL CONTENT YOU ADD IS HIGHLIGHTED IN BLUE SO THE REGISTRAR CAN EASILY IDENTIFY CHANGES DO NOT CHANGE OR DELETE CONTENT THAT IS NOT HIGHLIGHTED WITHOUT PRIOR WRITTEN APPROVAL FROM CPSM Clinical Assistant: INSERT NAME (hereinafter “Clinical Assistant”) Designated Primary Supervisor: INSERT NAME Date Practice Description approved by Registrar: [Insert date] Practice Location(s): INSERT LOCATION(S) Contents 1. Overview of the Practice Setting ......................................................................................... 2 2. Professional Practice of Clinical Assistant ............................................................................ 2 3. Prescribing and medications .............................................................................................. 22 4. Education and training ....................................................................................................... 23 5. Evaluation and assessment of performance ..................................................................... 24 6. College Reporting Requirements ....................................................................................... 29 Be advised that nothing in this document -
Managing Hyponatremia in Patients with Syndrome of Inappropriate Antidiuretic Hormone Secretion
REVIEW Managing Hyponatremia in Patients With Syndrome of Inappropriate Antidiuretic Hormone Secretion Joseph G. Verbalis, MD Division of Endocrinology and Metabolism, Department of Medicine, Georgetown University Medical Center, Washington DC. J.G. Verbalis received an honorarium funded by an unrestricted educational grant from Otsuka America Pharmaceuticals, Inc., for time and expertise spent in the composition of this article. No editorial assistance was provided. No other conflicts exist. This review will address the management of hyponatremia caused by the syndrome of inappropriate antidiuretic hormone secretion (SIADH) in hospitalized patients. To do so requires an understanding of the pathogenesis and diagnosis of SIADH, as well as currently available treatment options. The review will be structured as responses to a series of questions, followed by a presentation of an algorithm for determining the most appropriate treatments for individual patients with SIADH based on their presenting symptoms. Journal of Hospital Medicine 2010;5:S18–S26. VC 2010 Society of Hospital Medicine. Why is SIADH Important to Hospitalists? What Causes Hyponatremia in Patients with SIADH? Disorders of body fluids, and particularly hyponatremia, are Hyponatremia can be caused by 1 of 2 potential disruptions among the most commonly encountered problems in clinical in fluid balance: dilution from retained water, or depletion medicine, affecting up to 30% of hospitalized patients. In a from electrolyte losses in excess of water. Dilutional hypo- study of 303,577 laboratory samples collected from 120,137 natremias are associated with either a normal (euvolemic) patients, the prevalence of hyponatremia (serum [Naþ] <135 or an increased (hypervolemic) extracellular fluid (ECF) vol- mmol/L) on initial presentation to a healthcare provider was ume, whereas depletional hyponatremias generally are asso- 28.2% among those treated in an acute hospital care setting, ciated with a decreased ECF volume (hypovolemic). -
Vasculitis: Pearls for Early Diagnosis and Treatment of Giant Cell Arteritis
Vasculitis: Pearls for early diagnosis and treatment of Giant Cell Arteritis Mary Beth Humphrey, MD, PhD Professor of Medicine McEldowney Chair of Immunology [email protected] Office Phone: 405 271-8001 ext 35290 October 2019 Relevant Disclosure and Resolution Under Accreditation Council for Continuing Medical Education guidelines disclosure must be made regarding relevant financial relationships with commercial interests within the last 12 months. Mary Beth Humphrey I have no relevant financial relationships or affiliations with commercial interests to disclose. Experimental or Off-Label Drug/Therapy/Device Disclosure I will be discussing experimental or off-label drugs, therapies and/or devices that have not been approved by the FDA. Objectives • To recognize early signs of vasculitis. • To discuss Tocilizumab (IL-6 inhibitor) as a new treatment option for temporal arteritis. • To recognize complications of vasculitis and therapies. Professional Practice Gap Gap 1: Application of imaging recommendations in large vessel vasculitis Gap 2: Application of tocilizimab in treatment of giant cell vasculitis Cranial Symptoms Aortic Vision loss Aneurysm GCA Arm PMR Claudication FUO Which is not a risk factor or temporal arteritis? A. Smoking B. Female sex C. Diabetes D. Northern European ancestry E. Age Which is not a risk factor or temporal arteritis? A. Smoking B. Female sex C. Diabetes D. Northern European ancestry E. Age Giant Cell Arteritis • Most common form of systemic vasculitis in adults – Incidence: ~ 1/5,000 persons > 50 yrs/year – Lifetime risk: 1.0% (F) 0.5% (M) • Cause: unknown At risk: Women (80%) > men (20%) Northern European ancestry>>>AA>Hispanics Age: average age at onset ~73 years Smoking: 6x increased risk Kermani TA, et al Ann Rheum Dis.